TrialNutrition journal2015

Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients.

Inayat U Rahman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.